U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. RECOTHROM
  1. Approved Blood Products

STN: BL 125248
Proper Name: Thrombin, Topical (Recombinant)
Tradename: RECOTHROM
Manufacturer: Baxter Healthcare Corporation
Indication:

  • To aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical in adults and pediatric populations greater than or equal to one month of age.
  • RECOTHROM may be used in conjunction with an absorbable gelatin sponge, USP.

Product Information

Supporting Documents

Back to Top